Product Images Synagis
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Synagis NDC 66658-230 by Swedish Orphan Biovitrum Ab (publ), such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
syn01 0003 01
This is a description of a prescription drug called SYNAGIS® used for intramuscular injection only. It contains Palivizumab, a humanized monoclonal antibody used to treat Respiratory Syncytial Virus (RSV) infections. Each vial contains 50mg of Palivizumab per 0.5ml of solution, along with histidine, glycine, and chloride. The medicine does not contain preservatives, and the unused portion should be discarded. The recommended dose is 15mg/kg intramuscularly, and a doctor's prescription is required to use the drug.*
syn01 0003 02
This is a description for a medication called SYNAGIS (PALIVIZUMAB). It is for intramuscular injection only and each dose is 15 mg/kg. The medication comes in a container with the NDC code 66658-230-01. The text also includes a warning to discard any unused portion and the statement that it does not contain preservatives.*
syn01 0003 03
This is a description of a medication called SYNAGIS or Palivizumab. It is manufactured by a company called Swedish Orphan Biovirum AB in Stockholm, Sweden. The medication is an intramuscular injection used to treat respiratory syncytial virus (RSV) and contains 100mg Palivizumab, which is a recombinant humanized monoclonal antibody to RSV. It comes in a vial and each vial contains 1 mL of solution, which includes 39mg histidine, 0.1mg glycine, and 0.5mg chiorde, with no preservatives. The medication should be used immediately after drawing the dose into the syringe, and any unused portion should be discarded. The recommended dose is 15mg/kg, and the package insert should be consulted for further information.*
syn01 0003 04
This is a description of a prescription medication called SYNAGIS (Palivizumab) by Swedish Orphan. It is used for intramuscular injection to prevent respiratory syncytial virus (RSV) infections in infants and young children. The medication is supplied in a 100 mg/mL concentration and does not contain any preservatives. The recommended dose is 15 mg/kg. The National Drug Code (NDC) for this medication is 66658-231-01. This medication is available only by prescription.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.